GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BetterLife Pharma Inc (XCNQ:BETR) » Definitions » Equity-to-Asset

BetterLife Pharma (XCNQ:BETR) Equity-to-Asset : -36.87 (As of Oct. 2024)


View and export this data going back to 2017. Start your Free Trial

What is BetterLife Pharma Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. BetterLife Pharma's Total Stockholders Equity for the quarter that ended in Oct. 2024 was C$-9.99 Mil. BetterLife Pharma's Total Assets for the quarter that ended in Oct. 2024 was C$0.27 Mil.

The historical rank and industry rank for BetterLife Pharma's Equity-to-Asset or its related term are showing as below:

XCNQ:BETR' s Equity-to-Asset Range Over the Past 10 Years
Min: -143.04   Med: -3.23   Max: 0.92
Current: -36.87

During the past 13 years, the highest Equity to Asset Ratio of BetterLife Pharma was 0.92. The lowest was -143.04. And the median was -3.23.

XCNQ:BETR's Equity-to-Asset is ranked worse than
99% of 1502 companies
in the Biotechnology industry
Industry Median: 0.67 vs XCNQ:BETR: -36.87

BetterLife Pharma Equity-to-Asset Historical Data

The historical data trend for BetterLife Pharma's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BetterLife Pharma Equity-to-Asset Chart

BetterLife Pharma Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.32 -3.38 -3.34 -143.04 -33.26

BetterLife Pharma Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.00 -33.26 -13.63 -24.17 -36.87

Competitive Comparison of BetterLife Pharma's Equity-to-Asset

For the Biotechnology subindustry, BetterLife Pharma's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BetterLife Pharma's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BetterLife Pharma's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where BetterLife Pharma's Equity-to-Asset falls into.


;
;

BetterLife Pharma Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

BetterLife Pharma's Equity to Asset Ratio for the fiscal year that ended in Jan. 2024 is calculated as

Equity to Asset (A: Jan. 2024 )=Total Stockholders Equity/Total Assets
=-10.809/0.325
=

BetterLife Pharma's Equity to Asset Ratio for the quarter that ended in Oct. 2024 is calculated as

Equity to Asset (Q: Oct. 2024 )=Total Stockholders Equity/Total Assets
=-9.992/0.271
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BetterLife Pharma  (XCNQ:BETR) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


BetterLife Pharma Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of BetterLife Pharma's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


BetterLife Pharma Business Description

Traded in Other Exchanges
Address
1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and the European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumors to treat various types of cancer.
Executives
Steven Sangha 10% Security Holder
Ahmad Doroudian Director, Senior Officer
Robert Metcalfe Director
James Russell Starr Senior Officer